Role of Nursing in Managing Polypharmacy and Reducing Medication Errors in Older Adults
DOI:
https://doi.org/10.22399/ijcesen.4617Keywords:
Nursing, Polypharmacy, Older Adults, Medication Errors, Management, Drug InteractionsAbstract
The role of nursing in managing polypharmacy among older adults is crucial, given the complexity of their health profiles, which often involves multiple chronic conditions. Nurses are positioned uniquely to monitor medication regimens closely, educate patients and their families about the importance of adherence, and assess for potential drug interactions and side effects. Through comprehensive medication reviews, nurses can identify unnecessary medications, promote the use of evidence-based guidelines, and advocate for deprescribing when appropriate. By fostering strong communication channels between patients, caregivers, and other healthcare providers, nurses can mitigate the risks associated with polypharmacy, thereby enhancing patient outcomes and ensuring safer medication practices. In addition to managing polypharmacy, nurses play a pivotal role in reducing medication errors in older adults. They are often the primary point of contact in healthcare settings and can help ensure that medication administration is performed accurately and safely. By implementing standardized protocols, conducting thorough medication reconciliation, and utilizing technology such as electronic health records, nurses can significantly diminish the likelihood of errors. Furthermore, their emphasis on patient education empowers older adults to take an active role in their medication management, fostering a better understanding of their treatment plans. Ultimately, by combining clinical expertise with compassionate care, nurses are essential in advancing medication safety and improving the quality of healthcare for older adults.
References
1. Young E.H., Pan S., Yap A.G., Reveles K.R., Bhakta K. Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016. PLoS ONE. 2021;16:e0255642. DOI: 10.1371/journal.pone.0255642.
2. Tong A., Flemming K., McInnes E., Oliver S., Craig J. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med. Res. Methodol. 2012;12:181. DOI: 10.1186/1471-2288-12-181.
3. Midão L., Giardini A., Menditto E., Kardas P., Costa E. Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch. Gerontol. Geriatr. 2018;78:213–220. DOI: 10.1016/j.archger.2018.06.018.
4. Critical Appraisal Skills Programme CASP qualitative studies checklist. (accessed on 16 January 2022).
5. Sun W., Tahsin F., Barakat-Haddad C., Turner J.P., Haughian C.R., Abbass-Dick J. Exploration of home care nurse’s experiences in deprescribing of medications: A qualitative descriptive study. BMJ Open. 2019;9:e025606. DOI: 10.1136/bmjopen-2018-025606.
6. Foley R.A., Hurard L.L., Cateau D., Koutaissoff D., Bugnon O., Niquille A. Physicians’, nurses’ and pharmacists’ perceptions of determinants to deprescribing in nursing homes considering three levels of action: A qualitative study. Pharmacy. 2020;8:17. DOI: 10.3390/pharmacy8010017.
7. Pariseault C.A., Sharts-Hopko N., Blunt E. Nurse practitioners’ experiences of polypharmacy in community-dwelling older adults. J. Am. Assoc. Nurse Pract. 2020;33:811–817. DOI: 10.1097/JXX.0000000000000484.
8. Köberlein J., Gottschall M., Czarnecki K., Thomas A., Bergmann A., Voigt K. General practitioners’ views on polypharmacy and its consequences for patient health care. BMC Fam. Pract. 2013;14:119. DOI: 10.1186/1471-2296-14-119.
9. Skirbekk H., Nortvedt P. Inadequate treatment for elderly patients: Professional norms and tight budgets could cause “ageism” in hospitals. Health Care Anal. 2014;22:192–201. DOI: 10.1007/s10728-012-0207-2.
10. Doyle L., McCabe C., Keogh B., Brady A., McCann M. An overview of the qualitative descriptive design within nursing research. J. Res. Nurs. 2020;25:443–455. DOI: 10.1177/1744987119880234.
11. Danielsen B.V., Sand A.M., Rosland J.H., Førland O. Experiences and challenges of home care nurses and general practitioners in home-based palliative care-a qualitative study. BMC Palliat. Care. 2018;17:95. DOI: 10.1186/s12904-018-0350-0.
12. Bell H.T., Granas A.G., Enmarker I., Omli R., Steinsbekk A. Nurses’ and pharmacists’ learning experiences from participating in interprofessional medication reviews for elderly in primary health care - A qualitative study. BMC Fam. Pract. 2017;18:30. DOI: 10.1186/s12875-017-0598-0.
13. Hand B.N., Krause J.S., Simpson K.N. Polypharmacy and adverse drug events among propensity score matched privately insured persons with and without spinal cord injury. Spinal Cord. 2018;56:591–597. DOI: 10.1038/s41393-017-0050-2.
14. Chen C., Feng Z., Fu Q., Wang J., Zheng Z., Chen H., Feng D. Predictors of polypharmacy among elderly patients in China: The role of decision involvement, depression, and taking Chinese medicine behavior. Front. Pharmacol. 2021;12:745688. DOI: 10.3389/fphar.2021.745688.
15. Al Shemeili S., Klein S., Strath A., Fares S., Stewart D. An exploration of health professionals’ experiences of medicines management in elderly, hospitalised patients in Abu Dhabi. Int. J. Clin. Pharm. 2016;38:107–118. DOI: 10.1007/s11096-015-0212-2.
16. Masnoon N., Shakib S., Kalisch-Ellett L., Caughey G.E. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:230. DOI: 10.1186/s12877-017-0621-2.
17. Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2020;372:n71. DOI: 10.1136/bmj.n71.
18. Costa M., Correard F., Montaleytang M., Baumstarck K., Loubière S., Amichi K., Villani P., Honore S., Daumas A., Verger P. Acceptability of a novel telemedication review for older adults in nursing homes in France: A qualitative study. Clin. Interv. Aging. 2021;16:19–34. DOI: 10.2147/CIA.S283496.
19. Kim J., Parish A.L. Polypharmacy and medication management in older adults. Nurs. Clin. N. Am. 2017;52:457–468. DOI: 10.1016/j.cnur.2017.04.007.
20. Hansen C.R., Byrne S., O’Mahony D., Kearney P.M., Sahm L.J. Qualitative analysis of community pharmacists’ opinions on their involvement in reducing potentially inappropriate prescribing. Eur. J. Clin. Pharmacol. 2019;75:265–274. DOI: 10.1007/s00228-018-2578-2.
21. Mardani A., Griffiths P., Vaismoradi M. The role of the nurse in the management of medicines during transitional care: A systematic review. J. Multidiscip. Healthc. 2020;13:1347–1361. DOI: 10.2147/JMDH.S276061.
22. Dumbreck S., Flynn A., Nairn M., Wilson M., Treweek S., Mercer S.W., Alderson P., Thompson A., Payne K., Guthrie B. Drug-disease and drug-drug interactions: Systematic examination of recommendations in 12 UK national clinical guidelines. BMJ. 2015;350:h949. DOI: 10.1136/bmj.h949.
23. Eriksen C.U., Kyriakidis S., Christensen L.D., Jacobsen R., Laursen J., Christensen M.B., Frølich A. Medication-related experiences of patients with polypharmacy: A systematic review of qualitative studies. BMJ Open. 2020;10:e036158. DOI: 10.1136/bmjopen-2019-036158.
24. Yang C., Lee D.T.F., Wang X., Chair S.Y. Effects of a nurse-led medication self-management intervention on medication adherence and health outcomes in older people with multimorbidity: A randomised controlled trial. Int. J. Nurs. Stud. 2022;134:104314. DOI: 10.1016/j.ijnurstu.2022.104314.
25. Thomas J., Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med. Res. Methodol. 2008;8:45. DOI: 10.1186/1471-2288-8-45.
26. Pazan F., Wehling M. Polypharmacy in older adults: A narrative review of definitions, epidemiology and consequences. Eur. Geriatr. Med. 2021;12:443–452. DOI: 10.1007/s41999-021-00479-3.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
